RHPI:DRUG-DEVICE-TRIALS

Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss

by
Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss

FILE PHOTO: The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing Rights LONDON, Nov 13 (Reuters) – Novo Nordisk (NOVOb.CO) shares rose 3% on Monday as the market reacted to data the drugmaker presented over the weekend showing that the heart protective benefits of its popular obesity … Read more

Novo Nordisk says Wegovy heart benefits due to more than weight loss

by
Novo Nordisk says Wegovy heart benefits due to more than weight loss

A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights PHILADELPHIA, Nov 11 (Reuters) – Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more … Read more